Beta Bionics, Inc.

Beta Bionics is a medical technology company dedicated to simplifying diabetes management through the iLet Bionic Pancreas, an automated insulin delivery system for people with type 1 diabetes. The iLet eliminates the need for manual carbohydrate counting and insulin dose calculations by continuously analyzing data from compatible continuous glucose monitors (Dexcom G7 and FreeStyle Libre 3 Plus sensors) and automatically determining and delivering 100% of required insulin doses. The device features a color display, remote caregiver access capabilities through the Bionic Circle app, and an insulin pause function. Beta Bionics also offers the iLet Mirror Display for remote monitoring and is developing additional products including dual-hormone bionic pancreas and patch pump technologies. The company operates with a patient-centric mission founded by Ed Damiano, whose personal experience with his son's type 1 diabetes diagnosis drives innovation in reducing diabetes burden for individuals and families.